Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids

Comparison of Healthcare Utilization and Costs in Patients With Asthma Who Fluticasone/Salmeterol Inhalation Powder Versus Other Inhaled Corticosteroid(s) in Typical Clinical Practice Using Health Insurance Claims Data.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01332344

Enrollment

5180

Registered

2011-04-11

Start date

2009-06-30

Completion date

2010-06-30

Last updated

2017-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

fluticasone propionate/salmeterol combination, Asthma, inhaled corticosteroids, outcomes

Brief summary

The objective of this study is to compare healthcare utilization and costs in asthma patients who receive fluticasone propionate/salmeterol combination 100mcg/50mcg (FSC 100/50) or inhaled corticosteriods in typical clinical practice using a retrospective observational cohort study design of large managed care database.

Interventions

DRUGFluticasone propionate/salmeterol combination

Asthma subjects newly prescribed fluticasone propionate/salmeterol combination

DRUGInhaled corticosteroids

asthma subjects newly prescribed inhaled corticosteroids in clinical practice

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

12 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Subjects with asthma as determined by ICD-9 codes and asthma drug use * at least 12 years of age * treated with inhaled corticosteroids

Exclusion criteria

* Subjects with COPD or treatment for COPD

Design outcomes

Primary

Measure	Time frame	Description
To assess the difference in asthma related exacerbations	90 days post index	Asthma related exaceberation is defined as any asthma related emergency department visit, or inpatient visit or oral corticosteroid dispensing.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026